CDH2 and non-small cell lung carcinoma: Since E-cadherin, N-cadherin, and vimentin were major markers of EMT [16,17], these results suggested that the knockdown of FGF12-AS2 suppressed the progression of NSCLC through inhibiting the EMT process.